# XELJANZ XR
> **NDA208246** · New Drug Application · Sponsor: PFIZER · Approved 2016-02-23
## Drug
- **FDA Application Number:** NDA208246
- **Application type:** New Drug Application
- **Brand name:** XELJANZ XR
- **Generic name:** TOFACITINIB
- **Active ingredients:** TOFACITINIB CITRATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PFIZER
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2016-02-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208246)
---
*MORVS · CC0 1.0*